+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Home Infusion Therapy Market Size, Share & Trends Analysis Report By Application (Anti-Infective, Endocrinology), By Product (Infusion Pumps, IV Cannulas, Intravenous Sets, Needleless Connectors), And Segment Forecasts, 2019 - 2026

  • ID: 4031925
  • Report
  • Region: Global
  • 100 pages
  • Grand View Research
1 of 5

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Baxter
  • CareFusion Corporation
  • Fresenius Kabi
  • ICU Medical, Inc.
  • JMS Co. Ltd.
  • MORE
The global home infusion therapy market size is expected to reach USD 38.7 billion by 2026 registering a CAGR of 7.2% from 2019 to 2026, according to this new report. Rapid technological advancements are some major factors contributing to the market growth. Home infusion is gradually being considered as an alternative to extended stay in hospitals or nursing homes for patients suffering from chronic diseases. With the administration of medications in home settings, patients recover faster, are more comfortable, and save money. Several government and non-government programs aimed at reducing the burden of hospital stays by establishing infusion centers that provide quick IV infusion services are likely to have a positive impact on the market.

Furthermore, favorable government policies and regulations are expected to propel the industry growth. In addition, rising prevalence of diseases, such as Cardiovascular Diseases (CVDs), cancer, diabetes, and other life-threatening conditions, is expected to be a high impact rendering driver for the market. According to the WHO, at present, all the aforementioned diseases account for 60% of total deaths and 43% of the disease burden in U.S. This creates the need to infuse nutritional products that contain glutamine, phospholipids, glucose, and amino acids, which in turn, is expected to boost the market growth in the region.

Further key findings from the study suggest:
  • Infusion pumps led the product segment in 2018 owing to their extensive use for the delivery of fluids, such as medications and nutrients, during infusion therapy
  • Needleless connectors is the fastest-growing product segment over the forecast period. These devices provide protection from needlestick injuries
  • Anti-infective segment held the largest share in 2018 owing to a large number of procedures performed for administering antibiotics and antifungals
  • The chemotherapy segment is expected to witness lucrative growth during the forecast period on account of initiatives undertaken pertaining to cancer treatment, such as development of infusion centers by the Cancer Treatment Centers of America
  • The market is highly competitive and is marked by the presence of key companies, such as B. Braun Melsungen AG; ICU Medical, Inc.; Baxter; Fresenius Kabi AG; Caesarea Medical Electronics; Terumo Corporation; CareFusion Corporation; JMS Co. Ltd.; and Smiths Medical
  • Most of these companies focus on new product development to maintain their position in the global home infusion therapy market
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Baxter
  • CareFusion Corporation
  • Fresenius Kabi
  • ICU Medical, Inc.
  • JMS Co. Ltd.
  • MORE
Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 Internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity flow analysis (model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 List of Secondary Sources
1.8 Objectives
1.8.1 Objective 1
1.8.2 Objective 2
1.8.3 Objective 3
1.8.4 Objective 4

Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Penetration & Growth Prospect Mapping
2.3 Market Dynamics
2.3.1 Market driver analysis
2.3.1.1 Growing geriatric population base
2.3.1.2 Rising prevalence of chronic disorders
2.3.1.3 Rapid technological advancements
2.3.1.4 Growing incidence of hospital acquired infections
2.3.1.5 Home healthcare as cost effective alternative
2.3.1.6 Improving healthcare infrastructure in emerging economies
2.3.2 Market restrain analysis
2.3.2.1 Presence of complicated reimbursement framework and reimbursement cuts
2.4 Industry Analysis - Porter’s
2.4.1 Supplier Power: Moderate due to large number of manufacturers
2.4.2 Buyer Power: Moderate due to presence of players entering into long-term contract
2.4.3 Substitution Threat: Low due to no/ less external substitutes
2.4.4 Threat from new entrant: Moderate due to brand recognition of the existing players
2.4.5 Competitive rivalry: High due to increasing mergers & acquisitions by major players
2.5 PESTEL Analysis
2.5.1 Political Landscape
2.5.2 Environmental Landscape
2.5.3 Social Landscape
2.5.4 Technology Landscape
2.5.5 Legal Landscape
2.6 Major Deals & Strategic Alliances Analysis
2.6.1 Joint Ventures
2.6.2 Mergers & Acquisitions
2.6.3 Licensing & Partnership
2.6.4 Technology Collaborations
2.6.5 Strategic divestments
2.7 Procedure cost analysis/breakdown
2.8 List of Key End-users, by region / by product / by country
2.9 Technology Overview
2.9.1 Technology Timeline
2.10 Regulatory Framework
2.10.1 Reimbursement framework

Chapter 3 Home Infusion Therapy Market: Segment Analysis, By Product, 2014 - 2026 (USD Million)
3.1 Product Market Share Analysis, 2018 & 2026
3.2 Global Home Infusion Therapy Market, by Product, 2014 to 2026
3.3 Market Size & Forecasts and Trend Analysis, 2014 to 2026
3.3.1 Infusion pumps
3.3.1.1 Infusion Pumps Market, 2014 - 2026 (USD Million)
3.3.1.2 Ambulatory Infusion Pumps Market, 2014 - 2026 (USD Million)
3.3.1.3 Insulin Pumps Market, 2014 - 2026 (USD Million)
3.3.1.4 Syringe Pumps Market, 2014 - 2026 (USD Million)
3.3.1.5 Elastomeric Pumps Market, 2014 - 2026 (USD Million)
3.3.1.6 Patient Controlled Analgesics (Pca) Market, 2014 - 2026 (USD Million)
3.3.1.7 Volumetric Pumps Market, 2014 - 2026 (USD Million)
3.3.2 Intravenous Sets
3.3.3 Intravenous Sets Market, 2014 - 2026 (USD Million)
3.3.4 IV Cannulas
3.3.4.1 IV Cannulas Market, 2014 - 2026 (USD Million)
3.3.5 Needleless Connectors
3.3.5.1 Needleless Connectors Market, 2014 - 2026 (USD Million)

Chapter 4 Home Infusion Therapy Market: Segment Analysis, By Application, 2014 - 2026 (USD Million)
4.1 Application Market Share Analysis, 2018 & 2026
4.2 Global Home Infusion Therapy Market, by Application, 2014 to 2026
4.3 Market Size & Forecasts and Trend Analyses, 2014 to 2026
4.3.1 Anti-Infective
4.3.1.1 Anti-Infective Market, 2014 - 2026 (USD Million)
4.3.2 Endocrinology
4.3.2.1 Endocrinology Market, 2014 - 2026 (USD Million)
4.3.2.2 Diabetes Market, 2014 - 2026 (USD Million)
4.3.2.3 Others Market, 2014 - 2026 (USD Million)
4.3.3 Hydration Therapy
4.3.3.1 Hydration Therapy Market, 2014 - 2026 (USD Million)
4.3.3.2 Athletes Market, 2014 - 2026 (USD Million)
4.3.3.3 Others Market, 2014 - 2026 (USD Million)
4.3.4 Chemotherapy
4.3.4.1 Chemotherapy Market, 2014 - 2026 (USD Million)
4.3.5 Enteral Nutrition
4.3.5.1 Enteral Nutrition Market, 2014 - 2026 (USD Million)
4.3.6 Parenteral Nutrition
4.3.6.1 Parenteral Nutrition Market, 2014 - 2026 (USD Million)
4.3.7 Specialty Pharmaceuticals
4.3.7.1 Specialty Pharmaceuticals Market, 2014 - 2026 (USD Million)
4.3.8 Others
4.3.8.1 Others Market, 2014 - 2026 (USD Million)

Chapter 5 Home Infusion Therapy Market: Regional Market Analysis, By Product, 2014 - 2026 (USD Million)
5.1 Definition & Scope
5.2 Regional Market Share Analysis, 2018 & 2026
5.3 Regional Market Snapshot
5.4 Market Size, & Forecasts and Trend Analysis, 2018 to 2026
5.5 North America
5.5.1 North America home infusion therapy market estimates and forecast, by country, 2014 - 2026 (USD Million)
5.5.2 North America home infusion therapy market, by product, 2014 - 2026 (USD Million)
5.5.3 North America home infusion therapy market, by Appliction, 2014 - 2026 (USD Million)
5.5.4 U.S.
5.5.4.1 U.S. home infusion therapy market, 2014 - 2026 (USD Million)
5.5.5 Canada
5.5.5.1 Canada home infusion therapy market, 2014 - 2026 (USD Million)
5.6 Europe
5.6.1 Europe home infusion therapy market market, by country, 2014 - 2026 (USD Million)
5.6.2 Europe home infusion therapy market market, by product, 2014 - 2026 (USD Million)
5.6.3 Europe home infusion therapy market market, by Application, 2014 - 2026 (USD Million)
5.6.4 U.K.
5.6.4.1 U.K. home infusion therapy market, 2014 - 2026 (USD Million)
5.6.5 Germany
5.6.5.1 Germany home infusion therapy market, 2014 - 2026 (USD Million)
5.6.6 Spain
5.6.6.1 Spain home infusion therapy market, 2014 - 2026 (USD Million)
5.6.7 Italy
5.6.7.1 Italy home infusion therapy market, 2014 - 2026 (USD Million)
5.6.8 France
5.6.8.1 France home infusion therapy market, 2014 - 2026 (USD Million)
5.6.9 Russia
5.6.9.1 Russia home infusion therapy market, 2014 - 2026 (USD Million)
5.7 Asia Pacific
5.7.1 Asia Pacific home infusion therapy market, by country, 2014 - 2026 (USD Million)
5.7.2 Asia Pacific home infusion therapy market, by product, 2014 - 2026 (USD Million)
5.7.3 Asia Pacific home infusion therapy market, by application, 2014 - 2026 (USD Million)
5.7.4 Japan
5.7.4.1 Japan home infusion therapy market, 2014 - 2026 (USD Million)
5.7.5 China (Mainland)
5.7.5.1 China (Mainland) home infusion therapy market, 2014 - 2026 (USD Million)
5.7.6 Australia
5.7.6.1 Australia home infusion therapy market, 2014 - 2026 (USD Million)
5.7.7 South Korea
5.7.7.1 South Korea home infusion therapy market, 2014 - 2026 (USD Million)
5.8 Latin America
5.8.1 Latin America home infusion therapy market, by country, 2014 - 2026 (USD Million)
5.8.2 Latin America home infusion therapy market, by product, 2014 - 2026 (USD Million)
5.8.3 Latin America home infusion therapy market, by Application, 2014 - 2026 (USD Million)
5.8.4 Brazil
5.8.4.1 Brazil home infusion therapy market, 2014 - 2026 (USD Million)
5.8.5 Mexico
5.8.5.1 Mexico home infusion therapy market, 2014 - 2026 (USD Million)
5.8.6 Argentina
5.8.6.1 Argentina home infusion therapy market, 2014 - 2026 (USD Million)
5.9 MEA
5.9.1 MEA home infusion therapy market, 2014 - 2026 (USD Million)
5.9.2 MEA home infusion therapy market, by product, 2014 - 2026 (USD Million)
5.9.3 MEA home infusion therapy market, by application, 2014 - 2026 (USD Million)
5.9.4 South Africa
5.9.4.1 South Africa home infusion therapy market, 2014 - 2026 (USD Million)
5.9.5 Saudi Arabia
5.9.5.1 Saudi Arabia home infusion therapy market, 2014 - 2026 (USD Million)
5.9.6 UAE
5.9.6.1 UAE home infusion therapy market, 2014 - 2026 (USD Million)

Chapter 6 Home Infusion Therapy Market - Competitive Analysis
6.1 Recent Developments & Impact Analysis, By Key Market Participants
6.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
6.3 Public Companies
6.3.1 Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
6.3.2 Company Market Share/Ranking, by region
6.3.3 Competitive Dashboard Analysis
6.3.4 Market Differentiators
6.3.5 Synergy Analysis: Major Deals & Strategic Alliances
6.4 Private Companies
6.4.1 List of key emerging companies
6.4.2 Regional network map
6.4.3 Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
6.5 Strategy Framework
6.6 Company Profiles
6.6.1 B. Braun Melsungen AG
6.6.1.1 Company overview
6.6.1.2 Financial performance
6.6.1.3 Product benchmarking
6.6.1.4 Strategic initiatives
6.6.2 Baxter
6.6.2.1 Company overview
6.6.2.2 Financial performance
6.6.2.3 Product benchmarking
6.6.2.4 Strategic initiatives
6.6.3 Caesarea Medical Electronics
6.6.3.1 Company overview
6.6.3.2 Product benchmarking
6.6.3.3 Strategic initiatives
6.6.3.4 Strategic initiatives
6.6.4 CareFusion Corporation
6.6.4.1 Company overview
6.6.4.2 Financial performance
6.6.4.3 Product benchmarking
6.6.4.4 Strategic initiatives
6.6.5 Fresenius Kabi
6.6.5.1 Company overview
6.6.5.2 Financial performance
6.6.5.3 Product benchmarking
6.6.5.4 Strategic initiatives
6.6.6 ICU Medical, Inc.
6.6.6.1 Company overview
6.6.6.2 Financial performance
6.6.6.3 Product benchmarking
6.6.6.4 Strategic initiatives
6.6.7 JMS Co. Ltd.
6.6.7.1 Company overview
6.6.7.2 Financial performance
6.6.7.3 Product benchmarking
6.6.7.4 Strategic initiatives
6.6.8 Smiths Medical
6.6.8.1 Company overview
6.6.8.2 Financial performance
6.6.8.3 Product benchmarking
6.6.8.4 Strategic initiatives
6.6.9 Terumo Corporation
6.6.9.1 Company overview
6.6.9.2 Financial performance
6.6.9.3 Product benchmarking
6.6.9.4 Strategic initiatives
*Full List of Tables and Figures Available on Enquiry.
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • B. Braun Melsungen AG
  • Baxter
  • Caesarea Medical Electronics
  • CareFusion Corporation
  • Fresenius Kabi
  • ICU Medical, Inc.
  • JMS Co. Ltd.
  • Smiths Medical
  • Terumo Corporation
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4031925
Adroll
adroll